Cipla Limited (CIPLA) — Announcement
· NSE
Neutral
📢 Key Event
Cipla's ESG rating downgraded to 64 by ESGRisk.ai
💡 Investor Takeaway
The downgrade could prompt investors to reassess Cipla's ESG risk profile and its impact on long-term valuation.
⚠️ Risks
ESG rating downgrade may signal heightened scrutiny of sustainability practices
Cipla announced that ESG rating provider ESGRisk.ai downgraded its ESG rating from 68 to 64, reflecting a re-evaluation of publicly available information and new data considered during the assessment period, with the update communicated on June 24, 2026.
About Cipla Limited (CIPLA)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹1,15,682.55 Cr
P/E: 25.4
ROE: 14.6%
ROCE: 19.4%
Recent Announcements from Cipla Limited
-
Announcement — 12 July 2026
Cipla announced that Crisil ESG Ratings assigned it a Crisil ESG 69 and Crisil Core ESG 66 rating, received on 11 July 2026, as part of its compliance... -
🟡 Board Meeting — 4 July 2026
Cipla held its 90th AGM on 25 June 2026, highlighting ₹28,000+ crores revenue, 21% EBITDA margin, and [amount context mismatch] final dividend. Shareh... -
🟡 Board Meeting — 3 July 2026
Cipla held its 90th AGM on 25 June 2026, approving financial results, auditor appointments, and leadership changes, including Mr Achin Gupta as new MD... -
🔴 Announcement — 19 June 2026
No summary available -
🟡 Board Meeting — 16 June 2026
Cipla announced the appointment of Shivam Puri as CEO of One India Business and a Management Council member, effective 1 July 2026, alongside granting...
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when CIPLA files new disclosures
Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CIPLA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research